Lv5
810 积分 2021-11-30 加入
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer
2天前
已完结
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC
2天前
已完结
The Role of Salvage Resection After Definitive Radiation Therapy for Non-small Cell Lung Cancer
2天前
已完结
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non–small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)
29天前
已完结
Role of Pathological Single- and Multiple-N Descriptors in Resected Non-small Cell Lung Cancer
3个月前
已完结
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer
4个月前
已完结
Perioperative Nivolumab in Resectable Lung Cancer
4个月前
已完结
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
4个月前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
4个月前
已完结
Exploiting bacteria for cancer immunotherapy
4个月前
已完结
皖公网安备34019202002308
